Loading...

Notice

Check the various announcements of oncoMASTER.

[oncoMASTER Director's press release] "The Asian Oncology Society, led by Korea, China, and Japan, is challenging cancer diagnosis and treatment led by the U.S. and Europe. The Asian Oncology Society is in full swing... A paradigm shift from 'passive → active'" (2022. 06) 17. Daily Medi)

2024.02.07 14:37

[oncoMASTER Director's press release] "The Asian Oncology Society, led by Korea, China, and Japan, is challenging cancer diagnosis and treatment led by the U.S. and Europe. The Asian Oncology Society is in full swing... A paradigm shift from 'passive → active'" (2022. 06) 17. Daily Medi)

“The Asian Oncology Society, led by Korea, China, and Japan, is a challenge to cancer diagnosis and treatment led by the US and Europe. A paradigm shift from ‘passive → active’.”

The Asian Oncology Society (ASO) held an academic conference in Seoul, the capital of Korea, on the 16th.

At a press conference on the 16th, Chairman Kim Yeol-hong expressed confidence in the global cancer diagnosis and treatment paradigm that ASO will lead.

 

link

https://www.dailymedi.com/news/news_view.php?wr_id=885207

Source: Daily Medi (Reporter Daejin Park_2022. 06. 17)


ONCOCROSS Co., Ltd.

Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG

Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)

Email: oncocross@oncocross.com

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.

온코마스터 로고.